Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07480707

Can People Achieve a Target Omega-3 Index by Following a Personalized Omega-3 Dosing Regimen?

Effects of Using Personalized Dosage Recommendations of Parasol Omega-3 Fish Oil Based on Omega-3 Index Values: A Pilot Study

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
48 (estimated)
Sponsor
Fatty Acid Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this project is to evaluate the efficacy of personalized dosage recommendations of Parasol Omega-3 Fish Oil on achieving an Omega-3 Index of \>8% in individuals with a baseline Omega-3 Index \<8% over a 90-day period.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFish Oil SupplementationEnrolled participants will be instructed to start taking 2 capsules per day on the day they take their baseline O3I and once O3I results are available to adjust to a personalized dose of Fish Oil, based on their baseline Omega-3 Index, and instructed to continue their current omega-3 dietary intake. Recommendations will be: * O3I \> 6.8% but ≤ 8% - 1 capsule * O3I \> 5.5% but ≤ 6.8% - 2 capsules * O3I \> 4.4% but ≤ 5.5% - 3 capsules * O3I ≤ 4.4% - 4 capsules

Timeline

Start date
2026-05-01
Primary completion
2026-12-01
Completion
2026-12-15
First posted
2026-03-18
Last updated
2026-03-18

Source: ClinicalTrials.gov record NCT07480707. Inclusion in this directory is not an endorsement.